Identification of proteins that presented a significant decrease in their expression content. by Rubens D. M. Magalhães (395962)

Decrease in the frequency of FGF-2/EGF addition increases cell death in aOBSCs. by Vanesa Nieto-Estévez (107326)

“…Graphs show the percentage of cells in each group (<b>D</b>, E13.5 OBSCs; <b>H</b>, aOBSCs). The results represent the mean ± SEM from 3–5 passages from 2 different cell cultures per condition. …”

The decrease or inhibition of Hsp90 induced REST degradation. by Raúl Orozco-Díaz (7067624)

Silencing of TET3 acted to decrease mitochondrial respiration in N2A cells. by Valeria Leon Kropf (17797623)

Akt2 ablation resulted in a substantial decrease in cell proliferation and cell survival. by Stacey A. Santi (231259)

“…(<b>B</b>) Among three Akt isoforms, Akt2 ablation caused the greatest decrease in the colony forming ability. …”

Effect of MI to decrease depressive symptoms (fixed-effects model). by Kalayou Kidanu Berhe (9557751)

Learning corresponds with a decrease in intermediate-speed exploratory behaviors. by Caleb Kemere (452950)

Decreased level of TRAFD1 has minor effects on expression of osteoclast resorption factors. by Hanna Witwicka (741272)

Vitamin C decreases the obesogenic and hyperglycemic effect of invert sugar in prediabetic rats by Patrícia MOLZ (6744857)

“…Methods: One hundred-day-old Male Wistar rats with a mean weight of 336.58±23.43g were randomly assigned to the following groups: (1) control, receiving water (C); (2) invert sugar control, receiving a 32% watery solution of invert sugar; (3) vitamin C control, receiving a watery solution of vitamin C (60mg/L), and (4) vitamin C plus invert sugar, receiving a watery solution of vitamin C and invert sugar. …”

shRNA mediated silencing of CDK9 decreased proliferation of MM cells. by Su-Lin Lim (8997650)

Datasheet1_Impact of lockdown on children with type-1 diabetes: returning to the community was associated with a decrease in HbA1c.pdf by Benjamin Morat (17677977)

“…Patients having increased HbA1c were more frequently in contact with a suspected case of COVID-19 [OR 9.07 (2.15–53.66); p = 0.006], whereas patients having decreased HbA1c had the feeling of increase number of hypoglycemia [OR 0.19 (0.05–0.57); p = 0.006].…”

Datasheet2_Impact of lockdown on children with type-1 diabetes: returning to the community was associated with a decrease in HbA1c.pdf by Benjamin Morat (17677977)

“…Patients having increased HbA1c were more frequently in contact with a suspected case of COVID-19 [OR 9.07 (2.15–53.66); p = 0.006], whereas patients having decreased HbA1c had the feeling of increase number of hypoglycemia [OR 0.19 (0.05–0.57); p = 0.006].…”

Behavioral deficits correlate with decreasing PO₂ in cortical grey matter. by Thomas W. Johnson (437931)

“…Deficits were seen by day 7. 10/16 mice had a score > 4 and 3/16 had a score > 10. …”

Pre-treatment of EPO decreases caspase-3 activity in H/R induced H9C2 cells. by Asiya Parvin A (631990)

“…EPO decrease caspase-3 activity after H/R. H9C2 cells pretreated with wortmannin showed increase in caspase-3 activity. …”

C2GnT1 gene knockdown decreases C2-O-sLe^X glycoproteins and C2GnT1 activity. by Catherine A. St. Hill (357388)

Subjects:

Decreased capacity to infect is not correlated with a loss of metacyclic promastigotes. by Diana Moreira (186681)

Combined ethanol and cholesterol feeding decreases metalloproteinase expression in the liver. by Yasodha Krishnasamy (314409)

Inhibition of miR-630 led to decreased IR sensitivity. by Yan Zhang (8098)

Nrf2 activation decreases PMN ROS production in response to zymosan. by Doumet Georges Helou (7255823)

MCP-1-deficiency decreased CD11c-expressing cells via impairing the production of ROS and decreased activation of PLCγ2, Akt, and ERK upon M-CSF stimulation in BMM. by Woon-Ki Kim (447798)

“…<p>BMMs from WT (open bar) and MCP-1-KO mice (oblique-lined bar) were incubated in the presence of M-CSF (30 ng/ml) with U73122 (10 µM), Akt inhibitor IV (0.3 µM), PD098059 (5 µM), DPI (50 nM), NAC (3 mM), or H₂O₂ (300 µM) for 4 d (A). *, <i>P</i><0.05; ***, <i>P</i><0.001 compared with vehicle-treated WT cells. …”